Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Continuous Blood Glucose Monitoring Market Growth Performance Trended Historically, And What Lies Ahead?

The market for continuous blood glucose monitoring has seen considerable expansion in recent years. Projected growth is expected from $13.57 billion in 2024 to $14.87 billion in 2025, which is a compound annual growth rate (CAGR) of 9.6%. The surge in growth during the historical period can be traced back to factors such as the rise in diabetes cases, regulatory requirements, the need for remote monitoring, developing markets, and an increase in healthcare expenditure.

What Is the Forecast for the Continuous Blood Glucose Monitoring Market Size Through 2029?

Anticipated significant expansion can be predicted for the market size of continuous blood glucose monitoring in the forthcoming years. The market is projected to inflate to $23.15 billion by 2029 with a compound annual growth rate (CAGR) of 11.7%. The projected escalation during the forecasted period is due to factors like a growing aging demographic, an increase in home healthcare services, telehealth expansion, a rise in healthcare spending, and an increase in disposable income. Key trends expected to shape the forecast period comprise wearable integration, the advent of artificial intelligence and machine learning, improvements in sensor technology and accuracy, and industry collaborations and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13079&type=smp

What are the Key Market Players in Continuous Blood Glucose Monitoring Market and How They’re Evolving?

Major companies operating in the continuous blood glucose monitoring market include F. Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini Diagnostics, Johnson & Johnson Services Inc., Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality

What Are the Primary Growth Drivers in the Continuous Blood Glucose Monitoring Market?

The expansion of the continuous blood glucose monitoring market is anticipated due to the escalating prevalence of diabetes. Diabetes is defined as a medical condition where the levels of glucose in the blood sees an inconsistency. Devices that monitor blood glucose can contribute to the identification of trends and observations that offer a deeper understanding of a diabetic patient’s situation. To illustrate, recent data suggests that around 537 million adults of ages 20 to 79 are presently coping with diabetes worldwide, according to the International Diabetes Federation (IDF). This data reflects a substantial surge from previous estimations and underscores a disturbing rise in the frequency of diabetes. The IDF estimates the number to escalate to 643 million by 2030, and even further to 783 million by 2045. Hence, the growing prevalence of diabetes is propelling the growth of the continuous blood glucose monitoring market in the future.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13079&type=smp

What Are the Leading Segments in the Global Continuous Blood Glucose Monitoring Industry?

The continuous blood glucose monitoring market covered in this report is segmented –

1) By Component: Insulin Pumps, Sensors, Transmitters, Receivers

2) By Application: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients

3) By End User: Hospitals, Homecare Diagnostics, Other End Users

Subsegments:

1) By Insulin Pumps: Tubeless Insulin Pumps, Tubed Insulin Pumps, Patch Pumps

2) By Sensors: Continuous Glucose Monitoring Sensors, Flash Glucose Monitoring Sensors, Implantable Sensors

3) By Transmitters: Integrated Transmitters, Wireless Transmitters, Bluetooth-enabled Transmitters

4) By Receivers: Standalone Receivers, Smartphone Apps, Integrated Devices

What Are the Key Market Trends in the Continuous Blood Glucose Monitoring Industry?

The rise in technological developments is becoming a prominent trend in the continuous blood glucose monitoring market. Major players in the market are prioritizing the creation of advanced technological strategies to consolidate their market presence. For instance, in 2022, Philips broadened its collection of home care solutions for chronic obstructive pulmonary disease (COPD) patients with the introduction of the BiPAP A40 EFL. This non-invasive ventilator, engineered to increase patient comfort and decrease hospital readmissions, utilizes Philips’ unique ExpiraFlow technology. This technology enables medical professionals to automatically identify expiratory flow limitation (EFL) in COPD patients and offer appropriate therapy.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/continuous-blood-glucose-monitoring-global-market-report

What Is the Regional Outlook for the Continuous Blood Glucose Monitoring Market?

The countries covered in the continous blood glucose monitoring market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13079

This Report Delivers Insight On:

1. How big is the continuous blood glucose monitoring market, and how is it changing globally?

2. Who are the major companies in the continuous blood glucose monitoring market, and how are they performing?

3. What are the key opportunities and risks in the continuous blood glucose monitoring market right now?

4. Which products or customer segments are growing the most in the continuous blood glucose monitoring market?

5. What factors are helping or slowing down the growth of the continuous blood glucose monitoring market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model